Optimal Vascular and Parenchymal Contrast Enhancement: The Current State of the Art

被引:92
作者
Fleischmann, Dominik [1 ]
Kamaya, Aya [1 ]
机构
[1] Stanford Univ, Med Ctr, Dept Radiol, Stanford, CA 94305 USA
关键词
Computed tomography; Contrast medium enhancement; CT angiography; Cardiac CT; CT liver; CT pancreas; TUBE CURRENT MODULATION; SPIRAL CT-ANGIOGRAPHY; HEPATOCELLULAR-CARCINOMA; HEPATIC ENHANCEMENT; INDUCED NEPHROPATHY; AORTIC ENHANCEMENT; ADVERSE-REACTIONS; BOLUS GEOMETRY; BODY-WEIGHT; DELAY-TIME;
D O I
10.1016/j.rcl.2008.10.009
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A fundamental understanding of early arterial and parenchymal contrast medium (CM) dynamics is the basis for the design of CT scanning and injection protocols for state-of-the-art cardiovascular and body CT applications. Although normal parenchymal enhancement is primarily controlled by the total iodine dose injected per body weight, arterial enhancement is controlled by the iodine flux, the injection duration, and cardiac output. The technical capabilities of modern CT equipment allow and require precise scan timing to synchronize data acquisition with the desired phase of vascular enhancement (for CTA) and parenchymal enhancement (for liver and pancreatic CT). Automated tube current modulation and weight-based injection protocols allow individual optimization of radiation exposure and reduce interindividual variability of CM enhancement.
引用
收藏
页码:13 / +
页数:15
相关论文
共 39 条
[1]  
[Anonymous], MAN CONTR MED VERS 6
[2]   Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma [J].
Asayama, Y ;
Yoshimitsu, K ;
Irie, H ;
Tajima, T ;
Nishie, A ;
Hirakawa, M ;
Nakayama, T ;
Kakihara, D ;
Taketomi, A ;
Aishima, S ;
Honda, H .
RADIOLOGY, 2006, 238 (01) :150-155
[3]   Nephrotoxic effects in high-risk patients undergoing angiography. [J].
Aspelin, P ;
Aubry, P ;
Fransson, S ;
Strasser, R ;
Willenbrock, R ;
Berg, KJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (06) :491-499
[4]   Aortic and hepatic enhancement and tumor-to-liver contrast: Analysis of the effect of different concentrations of contrast material at multi-detector row helical CV [J].
Awai, K ;
Takada, K ;
Onishi, H ;
Hori, S .
RADIOLOGY, 2002, 224 (03) :757-763
[5]   Aortic and hepatic contrast medium enhancement at CT part II. Effect of reduced cardiac output in a porcine model [J].
Bae, KT ;
Heiken, JP ;
Brink, JA .
RADIOLOGY, 1998, 207 (03) :657-662
[6]   Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography - A double-blind comparison of iodixanol and iopamidol [J].
Barrett, Brendan J. ;
Katzberg, Richard W. ;
Thomsen, Henrik S. ;
Chen, Nan ;
Sahani, Dushyant ;
Soulez, Gilles ;
Heiken, Jay P. ;
Lepanto, Luigi ;
Ni, Zhou-Hui ;
Nelson, Rendon .
INVESTIGATIVE RADIOLOGY, 2006, 41 (11) :815-821
[7]   Assessment of a bolus-traching technique in helical renal CT to optimize nephrographic phase imaging [J].
Birnbaum, BA ;
Jacobs, JE ;
Langlotz, CP ;
Ramchandani, P .
RADIOLOGY, 1999, 211 (01) :87-94
[8]   BOLUS GEOMETRY AND DYNAMICS AFTER INTRAVENOUS CONTRAST-MEDIUM INJECTION [J].
CLAUSSEN, CD ;
BANZER, D ;
PFRETZSCHNER, C ;
KALENDER, WA ;
SCHORNER, W .
RADIOLOGY, 1984, 153 (02) :365-368
[9]   Contrast media as extracellular fluid space markers: Adaptation of the central volume theorem [J].
Dawson, P ;
Blomley, MJK .
BRITISH JOURNAL OF RADIOLOGY, 1996, 69 (824) :717-722
[10]  
DAWSON P, 1996, RADIOLOGY, V3, pS261